---
title: "Novoprotein: Net loss of 11.8084 million yuan in the first quarter of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237873324.md"
description: "Novoprotein announced that its revenue for the first quarter of 2025 was 33.4446 million yuan, a year-on-year increase of 28.20%; the net loss was 11.8084 million yuan, compared to a net loss of 2.6305 million yuan in the same period last year"
datetime: "2025-04-28T13:50:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237873324.md)
  - [en](https://longbridge.com/en/news/237873324.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237873324.md)
generator: "portal-rs"
---

# Novoprotein: Net loss of 11.8084 million yuan in the first quarter of 2025

Novoprotein announced that its revenue for the first quarter of 2025 was 33.4446 million yuan, a year-on-year increase of 28.20%; the net loss was 11.8084 million yuan, compared to a net loss of 2.6305 million yuan in the same period last year

### Related Stocks

- [688137.CN](https://longbridge.com/en/quote/688137.CN.md)

## Related News & Research

- [Gold Rallies to 3-Month High](https://longbridge.com/en/news/296629959.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [IMMU: Vididencel delivers durable remissions in AML and CML, with broad late-stage clinical expansion](https://longbridge.com/en/news/296462827.md)
- [Silver Pony Announces OTC Symbol Change to PONIF Following Name Change | CCCFD Stock News](https://longbridge.com/en/news/296454882.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**